PALI

Palisade Bio Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 8/10
  • Momentum↑ 8/10
Palisade Bio sales and earnings growth
PALI Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 84.86%
  • FCF Y/Y↑ 19.70%
Palisade Bio gross and profit margin trends
PALI Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 577.10%
Palisade Bio net debt vs free cash flow
PALI Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1019.5

Palisade Bio stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗